ABSTRACT
INTRODUCTION

38
knowledge database of prioritize biological outcomes, enabling users to obtain a comprehensive insight 101 of the transcriptome analyzed from the RNA samples. TED becomes extensible to applications in clinical 102 or diagnostic scenarios, allowing the user as a clinician or practitioner to leverage their experience to data 103 mine the reports of analyzed results for discovery or indication of biological candidates to examine.
104
We document an example use case of TED with previously published prostate cancer transcriptome 105 data (13) . We have developed a methodology that can provide the components of data analysis of complex 106 RNA-seq datasets through a toolkit interface that is easy to access, handle in addition to a comprehensive 107 data processing solution that is reusable and practical for users without extensive bioinformatics expertise. (Fig.1b) is the second module of TED comprised of five data analysis pipelines i) Alignment, ii) Novel Isoform, iii) Differential Gene Expression, iv) Isoform-activity and v) Variant analysis. This module consist of 14 bioinformatics tools and 24 steps that will analyze any number of paired-end RNA sequencing data samples from two conditions.
METHODS
110
Availability
111
The TED toolkit is freely accessible on our local instance of the Galaxy platform via a url link: The Transcriptome Data Analysis (Fig.1b) is the second module of TED comprised of five data analysis 
173
The Alignment (Fig. 1b.i.) (Fig. 1c.i.) , differential non-coding gene expression (Fig. 1c. ii.), differential 252 novel gene isoform expression (Fig. 1c. iii.), somatic genetic variants (Fig. 1c.iv.) , germ line genetic 253 variants (Fig. 1c.v.) , comparison of genetic variants between samples (Fig. 1vi.) , gene fusions (Fig.   254 1vii.), comparison of gene fusions between samples (Fig. 1c.viii.) , gene splicing events (Fig. 1c.ix.) , and 255 (Fig. 1c.x.) and Total regulated genes. Figure 2a illustrates an example of the total regulated html report for differential 263 coding gene expression of two sample RNAseq datasets (one sample for each condition), in which the pipeline will populate the report with the following information in 8 parts: i) total number of differentially expressed coding genes (Fig. 2a.i.) , ii) total number of significant genes (Fig. 2a.ii. 13. Ren,S., Peng,Z., Mao,J.-H., Yu,Y., Yin,C., Gao,X., Cui,Z., Zhang,J., Yi,K., Xu,W., et al. (2012) 
